搜尋結果
2024年4月30日 · Multisystem inflammatory syndrome in children (MIS-C) is a serious condition linked to infection with the virus that causes COVID-19. With MIS-C, children have fever, blood markers of inflammation and serious disease throughout the body. Organs such as the brain, eyes, heart, lungs, kidneys, digestive system and skin may become inflamed.
2 天前 · COVID-19 is characterized by a variety of symptoms, including fever, cough, congestion, fatigue, shortness of breath, headache, sore throat, nausea or vomiting, loss of smell or taste, and body aches. COVID-19 may progress to severe respiratory illness, with symptoms of chest pain and extreme difficulty in breathing, requiring hospitalization.
2024年5月5日 · Acute respiratory illness is an overall indicator and may be due to symptoms of various infections including COVID-19, influenza, RSV, Rhinovirus and others. Activity may be presented as low, moderate or high, and trend as stable, increasing or decreasing. Understanding current activity and trends of acute respiratory infections will help ...
2024年4月19日 · Vomiting and other gastrointestinal symptoms (like nausea, diarrhea, and abdominal pain) may be early signs of COVID-19 and may precede the respiratory symptoms of COVID by one or more days. Though the symptoms tend to last from a few days to a week in people with mild COVID-19, they can sometimes recur for months in people with long COVID.
2024年4月15日 · Toute l’actualité sur le sujet Coronavirus et pandémie de Covid-19. Consultez l’ensemble des articles, reportages, directs, photos et vidéos de la rubrique Coronavirus et pandémie ...
2024年5月2日 · PCR tests are the “gold standard” for COVID-19 tests. They are a type of nucleic acid amplification test (NAAT), which are more likely to detect the virus than antigen tests. Your sample will usually be taken by a healthcare provider and transported to a laboratory for testing. It may take up to 3 days to receive results.
2024年4月19日 · COVID vaccines are safe and effective, according to the CDC. The safety of COVID vaccines has been rigorously monitored and evaluated since their emergency use authorization (EUA) in December 2020. According to the CDC, the updated mRNA COVID vaccines for 2023-2024 are manufactured using a similar process to the previous vaccines.
